FDA PMA
FDA Class 3
Approved
🇺🇸 United States
Intracranial Coil-Assist Stent
PMA: P170013
·
Supplement: S009
·
Decision Jun 28, 2022
Classifications
1
FEI Numbers
6
Registration Numbers
6
Basic Information
- Device Name
- Intracranial Coil-Assist Stent
- Trade Name
- Low-Profile Visualized Intraluminal Support (LVIS) and LVIS Jr. X
- PMA Number
- P170013
- Supplement Number
- S009
- Device Class
- FDA Class 3
- Product Code
- QCA
- Generic Name
- Intracranial coil-assist stent
- Medical Specialty
- Unknown
- Advisory Committee
- Neurology
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- June 28, 2022
- Date Received
- June 10, 2022
- Supplement Type
- Normal 180 Day Track No User Fee
- Supplement Reason
- Postapproval Study Protocol
- Expedited Review
- N
Advisory Committee Statement
Approval to place the post-approval study titled LVIS X PAS on hold, because the sponsor does not intend to market the LVIS X and LVIS Jr. X devices in the United States at this time.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| QCA | Intracranial Coil-Assist Stent | FDA class 3 | Unknown |